Latest Insider Transactions at Phio Pharmaceuticals Corp. (PHIO)
This section provides a real-time view of insider transactions for Phio Pharmaceuticals Corp. (PHIO). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Phio Pharmaceuticals Corp. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Phio Pharmaceuticals Corp.'s insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Mar 03
2021
|
Robert L Ferrara Director |
BUY
Open market or private purchase
|
Direct |
682
+4.98%
|
$2,046
$3.15 P/Share
|
Mar 01
2021
|
Caitlin Kontulis Secretary & VP Finance & Admin |
BUY
Grant, award, or other acquisition
|
Direct |
34,600
+46.49%
|
-
|
Mar 01
2021
|
Gerrit Dispersyn President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
68,450
+44.66%
|
-
|
Mar 01
2021
|
Robert L Ferrara Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,000
+44.81%
|
-
|
Mar 01
2021
|
Robert J Bitterman Chairman, Pres & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
10,000
+38.72%
|
-
|
Mar 01
2021
|
Curtis Lockshin Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,000
+49.1%
|
-
|
Mar 01
2021
|
Jonathan E Freeman Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,000
+49.11%
|
-
|
Mar 01
2021
|
H. Paul Dorman Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,000
+49.09%
|
-
|
Mar 01
2021
|
Geert Cauwenbergh Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,000
+30.47%
|
-
|